Literature DB >> 19175884

Muscle relaxant use for tracheal intubation in pediatric anaesthesia: a survey of clinical practice in Germany.

D Nauheimer1, H Fink, Th Fuchs-Buder, G Geldner, R Hofmockel, K Ulm, B Wallek, M Blobner.   

Abstract

OBJECTIVES: Aim of this Germany-wide study was to evaluate the use and application customs of neuromuscular blocking drugs (NMBDs) for tracheal intubation in children of age 5 years or younger.
MATERIAL AND METHODS: In the year 2005, a total of 3260 questionnaires were sent out to all heads of anesthesia departments at all types of hospitals as well as ambulatory anesthesia centers in Germany. The fields covered by the questionnaire were regarding institutional size, amount of general anesthesia and specifically pediatric cases, number of intubations and NMBDs used, frequency of use of the individual relaxants and techniques utilized when administering muscle relaxants.
RESULTS: Of the sent-out questionnaires 66.9% could be analyzed: 82% of hospitals use 1-3 muscle relaxants in children; 91% of the ambulatory anesthesia centers use a repertoire of 1-2 neuromuscular blockers for pediatric cases. However, general anesthesia with tracheal intubation in children is often induced without using any NMBD at all. Mivacurium is the predominantly used NMBD for pediatric intubation in Germany. In contrast, the use of succinylcholine is far less in ambulatory anesthesia centers than in hospitals. Despite controversial discussion, precurarization, priming, and timing are still utilized in German anesthesia practice.
CONCLUSION: In Germany, mivacurium, with its favorable pharmacologic profile for short cases, is the predominantly used NMBD for pediatric tracheal intubation. Despite the known adverse effects of intubation without muscle relaxation, this technique is also wide-spread, especially among German anesthetists in ambulatory anesthesia centers. Surveys like these are important to determine a status quo of use and application customs of NMBDs in pediatric anesthesia and provide a basis for numerous other studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19175884     DOI: 10.1111/j.1460-9592.2008.02803.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  6 in total

1.  Use of Succinylcholine by Anaesthetists in Turkey: A National Survey.

Authors:  Dilek Ömür; Hasan Ali Kiraz; Hasan Şahin; Hüseyin Toman; Berna Uyan; Serpil Ekin; Volkan Hancı
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-08-21

2.  Update on perioperative management of the child with asthma.

Authors:  Francesco Dones; Grazia Foresta; Vincenzo Russotto
Journal:  Pediatr Rep       Date:  2012-04-05

3.  The efficacy and safety of mivacurium in pediatric patients.

Authors:  Ruifeng Zeng; Xiulan Liu; Jing Zhang; Ning Yin; Jian Fei; Shan Zhong; Zhiyong Hu; Miaofeng Hu; Mazhong Zhang; Bo Li; Jun Li; Qingquan Lian; Wangning ShangGuan
Journal:  BMC Anesthesiol       Date:  2017-04-17       Impact factor: 2.217

4.  Neuromuscular Blocking Agents and Monitoring in China: A Cross-Sectional Survey of Current Management.

Authors:  HaoTian Wu; ZengMao Lin; RuiHao Zhou; SuiSui Huang; LingJun Chen; Yang Su; LuoNa Cheng; Huan Zhang
Journal:  Front Med (Lausanne)       Date:  2022-04-27

5.  Crowdsourcing sugammadex adverse event rates using an in-app survey: feasibility assessment from an observational study.

Authors:  Craig S Jabaley; Francis A Wolf; Grant C Lynde; Vikas N O'Reilly-Shah
Journal:  Ther Adv Drug Saf       Date:  2018-04-18

6.  Application of Mivacurium in Fast-Track Anesthesia for Transthoracic Device Closure of Ventricular Septal Defects in Children.

Authors:  Jing Wang; Yu-Qing Lei; Jian-Feng Liu; Zeng-Chun Wang; Hua Cao; Qiang Chen
Journal:  Braz J Cardiovasc Surg       Date:  2022-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.